DSDavid Stevenson

David Stevenson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Stevenson has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phagocytes produce prostaglandin E2 in response to cytosolic Listeria monocytogenes

    by Courtney E. McDougal, Zachary T. Morrow, Tighe Christopher, Seonyoung Kim, Drake Carter, David M. Stevenson, Daniel Amador-Noguez, Mark J. Miller, John-Demian Sauer

    Listeria monocytogenesis an intracellular bacterium that elicits robust CD8+T-cell responses. Despite the ongoing development ofL.monocytogenes-based platforms as cancer vaccines, our understanding of howL.monocytogenesdrives robust CD8+T-cell responses remains incomplete. One overarching hypothesis is that activation of cytosolic innate pathways is critical for immunity, as strains ofL.monocytogenesthat are unable to access the cytosol fail to elicit robust CD8+T-cell responses and in fact inhibit optimal T-cell priming. Counterintuitively, however, activation of known cytosolic pathways, such as the inflammasome and type I IFN, lead to impaired immunity. Conversely, production of prostaglandin E2(PGE2) downstream of cyclooxygenase-2 (COX-2) is essential for optimalL.monocytogenesT-cell priming. Here, we demonstrate that vacuole-constrainedL.monocytogeneselicit reduced PGE2production compared to wild-type strains in macrophages and dendritic cellsex vivo.In vivo, infection with wild-typeL.monocytogenesleads to 10-fold increases in PGE2production early during infection whereas vacuole-constrained strains fail to induce PGE2over mock-immunized controls. Mice deficient in COX-2 specifically in Lyz2+or CD11c+cells produce less PGE2, suggesting these cell subsets contribute to PGE2levelsin vivo, while depletion of phagocytes with clodronate abolishes PGE2production completely. Taken together, this work demonstrates that optimal PGE2production by phagocytes depends onL.monocytogenesaccess to the cytosol, suggesting that one reason cytosolic access is required to prime CD8+T-cell responses may be to facilitate production of PGE2.


  • Open Access

    Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis

    by Laurence C. Cadalbert, Farah Naz Ghaffar, David Stevenson, Sheila Bryson, Frédéric M. Vaz, Eyal Gottlieb, Douglas Strathdee

    Barth syndrome is an X-linked mitochondrial disease, symptoms of which include neutropenia and cardiac myopathy. These symptoms are the most significant clinical consequences of a disease, which is increasingly recognised to have a variable presentation. Mutation in the Taz gene in Xq28 is thought to be responsible for the condition, by altering mitochondrial lipid content and mitochondrial function. Male chimeras carrying a targeted mutation of Taz on their X-chromosome were infertile. Testes from the Taz knockout chimeras were smaller than their control counterparts and this was associated with a disruption of the progression of spermatocytes through meiosis to spermiogenesis. Taz knockout ES cells also showed a defect when differentiated to germ cells in vitro. Mutant spermatocytes failed to progress past the pachytene stage of meiosis and had higher levels of DNA double strand damage and increased levels of endogenous retrotransposon activity. Altogether these data revealed a novel role for Taz in helping to maintain genome integrity in meiosis and facilitating germ cell differentiation. We have unravelled a novel function for the Taz protein, which should contribute to an understanding of how a disruption of the Taz gene results in the complex symptoms underlying Barth Syndrome.


  • Diplomats

    by David Stevenson

    The Cambridge History of the First World War - January 2014

  • Tissue inducible Lifeact expression allows visualization of actin dynamics in vivo and ex vivo

    by Hannah Schachtner, Ang Li, David Stevenson, Simon D.J. Calaminus, Steven G. Thomas, Steve P. Watson, Michael Sixt, Roland Wedlich-Soldner, Douglas Strathdee, Laura M. Machesky


  • Rac1 Drives Melanoblast Organization during Mouse Development by Orchestrating Pseudopod- Driven Motility and Cell-Cycle Progression

    by Ang Li, Yafeng Ma, Xinzi Yu, Richard L. Mort, Colin R. Lindsay, David Stevenson, Douglas Strathdee, Robert H. Insall, Jonathan Chernoff, Scott B. Snapper, et al.


  • Tissue selective expression of conditionally‐regulated ROCK by gene targeting to a defined locus

    by Michael S. Samuel, June Munro, Sheila Bryson, Stephen Forrow, David Stevenson, Michael F. Olson

    ROCK kinases regulate actin‐myosin structures downstream of Rho GTPases. We generated mice expressing 4‐hydroxytamoxifen (4HT)‐regulated human ROCK II (ROCKII:mER™) under the transcriptional control of the cytokeratin14 (K14) promoter. The K14‐ROCKII:mER™ minigene was recombineered into a novel cloning vector containing the promoter and first exon of the human HPRT gene, and second and third exons of the mouse Hprt gene. Homologous recombination into the Hprt locus, which is deleted for the promoter and first two exons in HM1 embryonic stem cells, reconstitutes a functional Hprt gene, allowing for growth in HAT (hypoxanthine‐aminopterin‐thymidine) medium. K14‐promoter‐driven ROCKII:mER™ expression was restricted to a superficial cell layer in embryoid bodies, with increased ROCK substrate phosphorylation induced by 4HT. ROCKII:mER™‐expressing primary murine keratinocytes responded to 4HT with increased substrate phosphorylation and cytoskeleton rearrangements, indicating that ROCKII:mER™ activity is regulated by 4HT in the target tissue. K14‐ROCKII:mER™ mice will be valuable for examining the role of ROCK in skin development and cancer. genesis 47:440–446, 2009.


  • Open Access

    Epstein-Barr Virus Latent Membrane Protein 1 (CAO) Up-regulates VEGF and TGFα Concomitant with Hyperlasia, with Subsequent Up-regulation of p16 and MMP9

    by David Stevenson, Chrystalla Charalambous, Joanna B. Wilson

    EBV latent membrane protein 1 (LMP1) is an oncoprotein frequently expressed in nasopharyngeal carcinoma. We have generated transgenic mice expressing the nasopharyngeal carcinoma–derived CAO strain of LMP1 and LMP1 of the B95-8 strain, using the viral ED-L2 promoter for epithelial expression. LMP1CAO and LMP1B95-8 induce transforming growth factor α expression and epidermal hyperplasia. However, levels of total epidermal growth factor receptor (EGFR) decline with the appearance of phosphorylated EGFR products, suggesting that the negative feedback loop upon EGFR expression is intact or that there is faster turnover at these early stages of carcinogenesis. In the L2LMP1CAO mice, increased levels of vascular endothelial growth factor are also seen at an early stage in the skin. As the phenotype worsens, with increasing hyperplasia and vascularization leading to keratoacanthoma, p16INK4a and matrix metalloproteinase 9 expression is induced. The lesions can progress spontaneously to carcinoma. Carcinoma cell lines developed from these mice show high levels of total and phosphorylated EGFR. These data show that the induction of signaling through EGFR by LMP1 is an early event in carcinogenesis and that any inhibition upon EGFR expression is lifted during progression. Furthermore, expression of LMP1 is not sufficient to inhibit induction of p16INK4a in response to abnormal proliferation. These data are consistent with the cooperative effects seen between LMP1 and loss of the INK4a locus in transgenic mice and with the frequency of loss of this locus in EBV-associated nasopharyngeal carcinoma.


  • Lindsay, Alexander, first earl of Balcarres (1618–1659), royalist army officer

    by David Stevenson

    Lindsay, Alexander, first earl of Balcarres (1618–1659), royalist army officer, eldest son of David, first Lord Lindsay of Balcarres (d. 1641) and Sophia Seton, daughter of the first earl of Dunfermline, was born on 6 July 1618 at Balcarres in Fife. He attended ...

  • The latent membrane protein 1 of Epstein-Barr virus and loss of the INK4a locus: paradoxes resolve to cooperation in carcinogenesis in vivo

    by Jennifer Macdiarmid, David Stevenson, Donald H. Campbell, Joanna B. Wilson

    Nasopharyngeal carcinoma (NPC) is the most tightly Epstein–Barr virus (EBV)-associated tumour. The EBV oncoprotein latent membrane protein 1 (LMP1) is frequently expressed in NPC tumours and may play a role in the genesis of the disease. NPC tumours often exhibit loss of expression (by deletion or methylation) of the INK4a locus, which encodes the tumour suppressor genes p16INK4a and p14ARF. To investigate the contribution of LMP1 and INK4a loss to tumourigenesis, skin chemical carcinogenesis was conducted using PyLMP1 and INK4a null mice. Surprisingly, INK4a null mice developed significantly fewer papillomas than wild-type mice, nevertheless, the papillomas that did develop grew faster and converted more rapidly to carcinoma than controls. This indicates that while loss of the INK4a locus plays an important role in the later stages of tumourigenesis, initially its loss inhibits papilloma formation. Conversely, LMP1 promoted papilloma formation but paradoxically inhibited papilloma growth. Using cross-breeds, it was found that LMP1 cooperates with loss of the INK4a locus during epithelial tumourigenesis. The expression of LMP1 overcame the inhibition of papilloma formation observed in INK4a null mice, whilst the loss of the INK4a locus counteracted the inhibition of papilloma growth rate found in PyLMP1 mice. This suggests that LMP1 mediates the inhibition of papilloma growth via one or both of the INK4a locus products. Intriguingly, mice heterozygous for INK4a loss showed lesion growth rates intermediate between wild-type and null, demonstrative of haploinsufficiency. We propose that LMP1 acts at the early stages in carcinogenesis to promote the development of benign tumours and that early reduction of INK4a locus expression allows these lesions to expand in size. In addition, loss of the INK4a locus accelerates the development of a more aggressive lesion. Conversely, complete loss of the INK4a locus in an otherwise normal cell might inhibit lesion formation.


  • Mapping and expression analysis of the human CASK gene

    by David Stevenson, Hugh G. Laverty, Sandra Wenwieser, Morag Douglas, Joanna B. Wilson